Bullboard - Stock Discussion Forum Indaptus Therapeutics Inc INDP

Healthcare Biotechnology

Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company, which specializes in cancer and viral infection treatments. The Company’s approach is based on the hypothesis that activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be... see more

Add To Watchlist

NDAQ:INDP - Post Discussion

Indaptus Therapeutics Inc > Indaptus Therapeutics Announces Positive Results from Second

View:

Post by whytestocks on Mar 04, 2024 12:15pm

Indaptus Therapeutics Announces Positive Results from Second

Just In: $INDP Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee to recommend initiating multi-dosing cohort • Single dose cohort data expected to be published at a scientific conference in 2024 NEW YORK, Marc...INDP - Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort